Petros Dimitriadis
6PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 28, 2026
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.Lotte L Hoeijmakers, Petros Dimitriadis, Steven C M A Wijnen
|Nov 13, 2023
Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma.Itske Fraterman, Irene L M Reijers, Petros Dimitriadis
|Mar 15, 2023
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.Irene L M Reijers, Disha Rao, Judith M Versluis
|Feb 08, 2023
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.Esmée P Hoefsmit, Paula T van Royen, Disha Rao
|Apr 27, 2022
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors.Paulien Kaptein, Celia Jacoberger-Foissac, Petros Dimitriadis
|Feb 09, 2021
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.E A Rozeman, E P Hoefsmit, I L M Reijers
Pageof 1
Frequent Collaborators
5 joint publications
Christian U Blank
4 joint publications
Georgina V Long
3 joint publications
Marta Lopez-Yurda
3 joint publications
Judith Versluis
3 joint publications
Daniel S Peeper
3 joint publications
Richard A Scolyer
2 joint publications
Robyn P M Saw
2 joint publications
Kerwin F Shannon
2 joint publications
Andrew J Spillane
2 joint publications
Disha Rao
